View in EDS

Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.

Saved in:
Bibliographic Details
Title: Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
Authors: Baharvand F; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Di Muro FM; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mohammadi A; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Aghajankhah M; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Parvaneh S; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Parsa NA; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran., Hassanipour S; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran., Aboutaleb E; Department of Pharmaceutics, School of pharmacy, Guilan University of Medical Sciences, Rasht, Iran., Jenab Y; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. yasjenab@gmail.com., Aliabadi SB; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42467386
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baharvand+F%22">Baharvand F</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Mehran+R%22">Mehran R</searchLink>; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Di+Muro+FM%22">Di Muro FM</searchLink>; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mohammadi+A%22">Mohammadi A</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Aghajankhah+M%22">Aghajankhah M</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Parvaneh+S%22">Parvaneh S</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Parsa+NA%22">Parsa NA</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Hassanipour+S%22">Hassanipour S</searchLink>; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Aboutaleb+E%22">Aboutaleb E</searchLink>; Department of Pharmaceutics, School of pharmacy, Guilan University of Medical Sciences, Rasht, Iran.<br /><searchLink fieldCode="AU" term="%22Jenab+Y%22">Jenab Y</searchLink>; Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. yasjenab@gmail.com.<br /><searchLink fieldCode="AU" term="%22Aliabadi+SB%22">Aliabadi SB</searchLink>; Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2026 Jul 17. <i>Date of Electronic Publication: </i>2026 Jul 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42467386
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40256-026-00814-8
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baharvand F
      – PersonEntity:
          Name:
            NameFull: Mehran R
      – PersonEntity:
          Name:
            NameFull: Di Muro FM
      – PersonEntity:
          Name:
            NameFull: Mohammadi A
      – PersonEntity:
          Name:
            NameFull: Aghajankhah M
      – PersonEntity:
          Name:
            NameFull: Parvaneh S
      – PersonEntity:
          Name:
            NameFull: Parsa NA
      – PersonEntity:
          Name:
            NameFull: Hassanipour S
      – PersonEntity:
          Name:
            NameFull: Aboutaleb E
      – PersonEntity:
          Name:
            NameFull: Jenab Y
      – PersonEntity:
          Name:
            NameFull: Aliabadi SB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 07
              Text: 2026 Jul 17
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-187X
          Titles:
            – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions
              Type: main
ResultId 1